Hyaluronic Acid-based Biomaterials increases from 162.91 million USD in 2011 to 185.05 million USD

The revenue of Hyaluronic Acid-based Biomaterials increases from 162.91 million USD in 2011 to 185.05 million USD in 2016, the global Hyaluronic Acid-based Biomaterials market is expected to reach 216.03 million USD by 2021, posting a CAGR of 3.15%. In 2016, the global Hyaluronic Acid-based Biomaterials market is led by China. Japan is the second-largest region-wise market.
 

At present, the major manufacturers of Hyaluronic Acid-based Biomaterials are concentrated in Bloomage BioTechnology, Shandong Galaxy Bio-Tech, Kewpie, CPN, China Eastar and FocusChem Biotech. Bloomage BioTechnology is the world leader, holding 42.08% production market share in 2016. 

In China, Hyaluronic Acid-based Biomaterials have a certain market as the popularity of Cosmetic Grade. In the consumption market, China is the largest consumption market, which consumption reached 74.52 MT in 2016. The consumption share of China is 27.15% in 2016.